(Q43643456)
Statements
A phase II trial of the cyclin-dependent kinase inhibitor flavopiridol in patients with previously untreated stage IV non-small cell lung cancer (English)
Shapiro GI
Supko JG
Patterson A
Lynch C
Lucca J
Zacarola PF
Muzikansky A
Wright JJ
Lynch TJ Jr